Eiko Yamamoto

Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer

Kazuhiko Ino, Norio Yoshida, Hiroaki Kajiyama et al. · British Journal of Cancer · 2006 · 254 citations · Full text

Medicine, Cancer Biology, Oncology +16

Inverse Correlation between Tumoral Indoleamine 2,3-Dioxygenase Expression and Tumor-Infiltrating Lymphocytes in Endometrial Cancer: Its Association with Disease Progression and Survival

Kazuhiko Ino, Eiko Yamamoto, Kiyosumi Shibata et al. · Clinical Cancer Research · 2008 · 236 citations · Full text

Medicine, Immunology, Oncology +17

Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

Rika Kihara, Yasunobu Nagata, Hitoshi Kiyoi et al. · Leukemia · 2014 · 233 citations · Full text

Life Sciences, Genetics, Oncology +17

Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma

Tomoko Inaba, Kazuhiko Ino, Hiroaki Kajiyama et al. · Gynecologic Oncology · 2009 · 212 citations

Medicine, Cancer Biology, Oncology +14

Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival

Kazuhiko Ino, Kiyosumi Shibata, Hiroaki Kajiyama et al. · British Journal of Cancer · 2006 · 125 citations · Full text

Medicine, Cancer Biology, Oncology +17